Retrospective Study to Evaluate the Safety of Duvie in Korean Patients With Type 2 Diabetes Mellitus

NCT05043467 · clinicaltrials.gov ↗

COMPLETED

Status

2228

Enrollment

INDUSTRY

Sponsor class

Conditions

Type2 Diabetes

Interventions

DRUG: Duvie(Lobeglitazone) tab 0.5mg

Sponsor

Chong Kun Dang Pharmaceutical